International Clinical Trial: A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through Menopause

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829653) titled 'A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through Menopause' on Sept. 15.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Astellas Pharma Inc

Condition: Hot Flashes

Intervention: Drug: Fezolinetant

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October 31, 2026

Target Sample Size: 100

To know more, visit https://clinicaltrials.gov/study/NCT07829653

Published by HT Digital Content Services with permission...